Page last updated: 2024-10-30

beta-lapachone and Acute Confusional Senile Dementia

beta-lapachone has been researched along with Acute Confusional Senile Dementia in 1 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Research Excerpts

ExcerptRelevanceReference
"Inflammatory diseases such as bacterial diseases, Alzheimer's disease, rheumatoid arthritis, multiple sclerosis, and so on, impose huge costs on the health systems."2.66An evaluation on potential anti-inflammatory effects of β-lapachone. ( Fathi Maroufi, N; Karimi, P; Kazemzadeh, H; Mokarizadeh, N; Nikanfar, S; Rashtchizadeh, N; Sadigh-Eteghad, S, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mokarizadeh, N1
Karimi, P1
Kazemzadeh, H1
Fathi Maroufi, N1
Sadigh-Eteghad, S1
Nikanfar, S1
Rashtchizadeh, N1

Reviews

1 review available for beta-lapachone and Acute Confusional Senile Dementia

ArticleYear
An evaluation on potential anti-inflammatory effects of β-lapachone.
    International immunopharmacology, 2020, Volume: 87

    Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bacterial Infections; H

2020